Ilias Alevizos
Overview
Explore the profile of Ilias Alevizos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
2001
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
St Clair E, Baer A, Ng W, Noaiseh G, Baldini C, Tarrant T, et al.
Nat Med
. 2024 Jun;
30(6):1583-1592.
PMID: 38839899
Sjögren's disease (SjD) is a chronic, systemic autoimmune disease with no approved disease-modifying therapies. Dazodalibep (DAZ), a novel nonantibody fusion protein, is a CD40 ligand antagonist that blocks costimulatory signals...
2.
Gupta S, Yamada E, Nakamura H, Perez P, Pranzatelli T, Dominick K, et al.
Ann Rheum Dis
. 2024 Mar;
83(8):1034-1047.
PMID: 38527764
Objectives: Inflammatory cytokines that signal through the Janus kinases-signal transducer and activator of transcription (JAK-STAT) pathway, especially interferons (IFNs), are implicated in Sjögren's disease (SjD). Although inhibition of JAKs is...
3.
Gupta S, Yamada E, Nakamura H, Perez P, Pranzatelli T, Dominick K, et al.
medRxiv
. 2023 Sep;
PMID: 37662351
Objectives: Inflammatory cytokines that signal through the JAK- STAT pathway, especially interferons (IFNs), are implicated in Sjögren's Disease (SjD). Although inhibition of JAKs is effective in other autoimmune diseases, a...
4.
Kivitz A, Wang L, Alevizos I, Gunsior M, Falloon J, Illei G, et al.
RMD Open
. 2023 Aug;
9(3).
PMID: 37541743
Objectives: To evaluate the safety, efficacy and response duration of four different dosing regimens of dazodalibep (DAZ), a non-antibody biological antagonist of CD40L, in patients with rheumatoid arthritis (RA). Methods:...
5.
Khatri B, Tessneer K, Rasmussen A, Aghakhanian F, Reksten T, Adler A, et al.
Nat Commun
. 2023 Feb;
14(1):598.
PMID: 36737443
No abstract available.
6.
Khatri B, Tessneer K, Rasmussen A, Aghakhanian F, Reksten T, Adler A, et al.
Nat Commun
. 2022 Nov;
13(1):6519.
PMID: 36316359
No abstract available.
7.
Khatri B, Tessneer K, Rasmussen A, Aghakhanian F, Reksten T, Adler A, et al.
Nat Commun
. 2022 Jul;
13(1):4287.
PMID: 35896530
Sjögren's disease is a complex autoimmune disease with twelve established susceptibility loci. This genome-wide association study (GWAS) identifies ten novel genome-wide significant (GWS) regions in Sjögren's cases of European ancestry:...
8.
Di Pasquale G, Perez Riveros P, Tora M, Sheikh T, Son A, Teos L, et al.
Mol Ther Methods Clin Dev
. 2020 Dec;
19:459-466.
PMID: 33294494
The loss of salivary gland function caused by radiation therapy of the head and neck or autoimmune disease such as Sjögren's syndrome is a serious condition that affects a patient's...
9.
Qu P, Wuest T, Min Y, Alevizos I, Young H, Lin P
J Autoimmun
. 2020 Oct;
116:102559.
PMID: 33087256
Autoimmune disorders are the third most common diseases in the United States, and affect the daily lives of millions of people. In this study, we analyzed patient samples, utilized a...
10.
Cortes-Troncoso J, Jang S, Perez P, Hidalgo J, Ikeuchi T, Greenwell-Wild T, et al.
JCI Insight
. 2020 May;
5(9).
PMID: 32376798
Sjögren's syndrome (SS) is a systemic autoimmune disease that mainly affects exocrine salivary and lacrimal glands. Local inflammation in the glands is thought to trigger glandular dysfunction and symptoms of...